ImmunityBio Inc. Common Stock vs Sasol Ltd. American Depositary Shares — how do they compare? ImmunityBio Inc. Common Stock trades at $10.7 (market cap $10.51B), while Sasol Ltd. American Depositary Shares trades at $15.18 (market cap $9.69B). The key difference: ImmunityBio Inc. Common Stock and Sasol Ltd. American Depositary Shares are close in size by market cap, and ImmunityBio Inc. Common Stock is more actively traded (10,445,785 versus 2,297,057). Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 1 Days and Sasol Ltd. American Depositary Shares for 0 Days on average.
| IBRX | SSL | |
|---|---|---|
Market Cap | $10.51B | $9.69B |
Volume | 10,445,785 | 2,297,057 |
Sector | Health | Basic Materials |
52-Week High | $11.55 | $15.14 |
52-Week Low | $1.98 | $5.33 |
Typical Hold Time | 1 Days | 0 Days |
Enterprise Value | $10.97B | $13.39B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →Sasol Limited is a Johannesburg-headquartered chemicals and energy company that uses its proprietary Fischer-Tropsch technology to convert coal, natural gas, and crude-oil feedstocks into fuels and chemical products such as polymers, solvents, surfactants, and ammonia, with operations across Southern Africa and international chemical manufacturing sites, including in US.
Read more on SSL →